LifeMD (NASDAQ:LFMDP) Stock Price Up 0.5% – What’s Next?

Shares of LifeMD, Inc. (NASDAQ:LFMDPGet Free Report) traded up 0.5% during trading on Thursday . The stock traded as high as $22.63 and last traded at $22.75. 656 shares were traded during mid-day trading, a decline of 81% from the average session volume of 3,477 shares. The stock had previously closed at $22.63.

LifeMD Trading Down 0.1%

The business’s 50-day moving average is $23.51 and its two-hundred day moving average is $23.74.

LifeMD (NASDAQ:LFMDPGet Free Report) last issued its quarterly earnings data on Thursday, May 13th. The company reported ($0.38) earnings per share (EPS) for the quarter. The business had revenue of $19.50 million for the quarter.

LifeMD Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, October 15th. Shareholders of record on Friday, October 3rd were paid a $0.5547 dividend. This represents a $2.22 dividend on an annualized basis and a yield of 9.8%. The ex-dividend date was Friday, October 3rd.

LifeMD Company Profile

(Get Free Report)

LifeMD, Inc operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies.

See Also

Receive News & Ratings for LifeMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeMD and related companies with MarketBeat.com's FREE daily email newsletter.